1. Home
  2. OLMA vs AMPX Comparison

OLMA vs AMPX Comparison

Compare OLMA & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • AMPX
  • Stock Information
  • Founded
  • OLMA 2006
  • AMPX 2008
  • Country
  • OLMA United States
  • AMPX United States
  • Employees
  • OLMA N/A
  • AMPX N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • AMPX Industrial Machinery/Components
  • Sector
  • OLMA Health Care
  • AMPX Miscellaneous
  • Exchange
  • OLMA Nasdaq
  • AMPX Nasdaq
  • Market Cap
  • OLMA 289.0M
  • AMPX 331.4M
  • IPO Year
  • OLMA 2020
  • AMPX N/A
  • Fundamental
  • Price
  • OLMA $4.42
  • AMPX $2.14
  • Analyst Decision
  • OLMA Strong Buy
  • AMPX Strong Buy
  • Analyst Count
  • OLMA 3
  • AMPX 8
  • Target Price
  • OLMA $27.67
  • AMPX $8.75
  • AVG Volume (30 Days)
  • OLMA 1.2M
  • AMPX 3.7M
  • Earning Date
  • OLMA 05-07-2025
  • AMPX 05-08-2025
  • Dividend Yield
  • OLMA N/A
  • AMPX N/A
  • EPS Growth
  • OLMA N/A
  • AMPX N/A
  • EPS
  • OLMA N/A
  • AMPX N/A
  • Revenue
  • OLMA N/A
  • AMPX $24,167,000.00
  • Revenue This Year
  • OLMA N/A
  • AMPX $167.05
  • Revenue Next Year
  • OLMA N/A
  • AMPX $216.14
  • P/E Ratio
  • OLMA N/A
  • AMPX N/A
  • Revenue Growth
  • OLMA N/A
  • AMPX 166.95
  • 52 Week Low
  • OLMA $2.86
  • AMPX $0.61
  • 52 Week High
  • OLMA $16.62
  • AMPX $4.21
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 60.78
  • AMPX 41.42
  • Support Level
  • OLMA $2.96
  • AMPX $2.28
  • Resistance Level
  • OLMA $3.41
  • AMPX $2.56
  • Average True Range (ATR)
  • OLMA 0.35
  • AMPX 0.25
  • MACD
  • OLMA 0.16
  • AMPX -0.04
  • Stochastic Oscillator
  • OLMA 98.73
  • AMPX 5.88

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About AMPX Amprius Technologies Inc.

Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.

Share on Social Networks: